Towards a protocol for the preparation and delivery of striatal tissue for clinical trials of transplantation in Huntington's disease

Cell Transplantation

Volumn 9, Issue 2, 2000, Pages 223-234

  Watts, Colin ^a,b   Dunnett, Stephen B ^a,c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UK   (United Kingdom)

Author keywords

Clinical trial protocol; Donor tissue preparation; Huntington's disease

Indexed keywords

NUCLEAR PROTEIN; RECEPTOR;

ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CORPUS STRIATUM; FOLLOW UP; GRAFT SURVIVAL; HUMAN; HUNTINGTON CHOREA; NONHUMAN; PATIENT SELECTION; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; TRANSPLANTATION;

ANIMALIA;

EID: 0034026851     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.1177/096368970000900208     Document Type: Article

References (104)

1. Alexander, G. E.; Crutcher, M. D. Functional architecture of basal ganglia circuits: Neural substrates of parallel processing. Trends Neurosci. 13:266-271; 1990.
2. Bayer, S. A. Neurogenesis in the rat neostriatum. Int. J. Dev. Neurosci. 2:163-175; 1984.
3. Bayer, S. A. Development of the lateral and medial limbic cortices in the rat in relation to cortical phylogeny. Exp. Neurol. 107:118-131; 1990.
4. Beal, M. F.; Kowall, N. W.; Swartz, K. J.; Ferrante, R. J.; Martin, J. B. Differential sparing of somatostatin-neuropeptide Y and cholinergic neurons following striatal excitotoxin lesions. Synapse 3:38-47; 1989.
5. Belkadi, A. M.; Geny, C.; Naimi, S.; Jeny, R.; Peschanski, M.; Riche, D. Maturation of fetal human neural xenografts in the adult rat brain. Exp. Neurol. 144:369-380; 1997.
6. Bernard, V.; Legay, C.; Massoulie, J.; Bloch, B. Anatomical analysis of the neurons expressing the acetylcholinesterase gene in the rat brain, with special reference to the striatum. Neuroscience 64:995-1005; 1995.
7. Björklund, A.; Stenevi, U. Intracerebral neural implants: Neuronal replacement and reconstruction of damaged circuitries. Annu. Rev. Neurosci. 7:279-308; 1984.
8. Björklund, A.; Campbell, K.; Sirinathsinghji, D. J. S.; Fricker, R. A.; Dunnett, S. B. Functional capacity of striatal transplants in the rat Huntington model. In: Dunnett, S. B.; Björklund, A., eds. Functional neural transplantation. New York: Raven Press; 1994:157-195.
9. Bolam, P. J. Synapses of identified neurons in the neostriatum. In: Evered, D.; O'Connor, M., eds. Functions of the basal ganglia: Chiba Foundation Symposium. London: Pitman; 1984:30-47.
10. Brownell, A. L.; Hantraye, P.; Wullner, U.; Hamberg, L.; Shoup, T.; Elmaleh, D. R.; Frim, D. M.; Madras, B. K.; Brownell, G. L.; Rosen, B. R. PET- and MRI-based assessment of glucose utilization, dopamine receptor binding, and hemodynamic changes after lesions to the caudate-putamen in primates. Exp. Neurol. 125:41-51; 1994.
11. Brundin, P.; Fricker, R. A.; Nakao, N. Paucity of P-zones in striatal grafts prohibit commencement of clinical trials in Huntington's disease. Neuroscience 71:895-897; 1996.
12. Butcher, L.; Wolf, N. Histochemical distribution of acetylcholinesterase in the central nervous system: Clues to the localisation of cholinergic neurons. In: Björklund, A.; Hokfelt, T.; Kuhar, M., eds. Handbook of chemical neuroanatomy, vol. 3. Amsterdam: Elsevier; 1984:1-50.
13. Deacon, T. W.; Pakzaban, P.; Isacson, O. The lateral ganglionic eminence is the origin of cells committed to striatal phenotypes: Neural transplantation and developmental evidence. Brain Res. 668:211-219; 1994.
14. De Carlos, J. A.; Lopez-Mascaraque, L.; Valverde, F. Dynamics of cell migration from the lateral ganglionic eminence in the rat. J. Neurosci. 16:6146-6156; 1996.
15. Deckel, A. W.; Moran, T. H.; Coyle, J. T.; Sanberg, P. R.; Robinson, R. G. Anatomical predictors of behavioral recovery following fetal striatal transplants. Brain Res. 365:249-258; 1986.
16. Deckel, A. W.; Moran, T. H.; Robinson, R. G. Behavioral recovery following kainic acid lesions and fetal implants of the striatum occurs independent of dopaminergic mechanisms. Brain Res. 363:383-385; 1986.
17. Deckel, A. W.; Moran, T. H.; Robinson, R. G. Receptor characteristics and recovery of function following kainic acid lesions and fetal transplants of the striatum. I. Cholinergic systems. Brain Res. 474:27-38; 1988.
18. Deckel, A. W.; Moran, T. H.; Robinson, R. G. Receptor characteristics and recovery of function following kainic acid lesions and fetal transplants of the striatum. II. Dopaminergic systems. Brain Res. 474:39-47; 1988.
19. Difiglia, M.; Schiff, L.; Deckel, W. Neuronal organization of fetal striatal grafts in kainate and sham lesioned rat caudate nucleus: Light and electron microsopic observations. J. Neurosci. 8:1112-1130; 1988.
20. Dunnett, S. B. Functional repair of striatal systems by neural transplants: Evidence for circuit reconstruction. Behav. Brain Res. 66:133-142; 1995.
21. Dunnett, S. B.; Björklund, A. Mechanisms of function of neural grafts in the injured brain. In: Dunnett, S. B.; Björklund, A., eds. Functional neural transplantation. New York: Raven Press; 1994:531-567.
22. Dunnett, S. B.; Isacson, O.; Sirinathsinghji, D. J. S.; Clarke, D. J.; Björklund, A. Striatal grafts in rats with unilateral striatal lesions. III. Recovery from dopamine dependent motor asymmetry and deficits in skilled paw reaching. Neuroscience 24:813-820; 1988.
23. Dunnett, S. B.; Iversen, S. Sensorimotor impairments following localized kainic acid and 6-hydroxydopamine lesions of the neostriatum. Brain Res. 248:121-127; 1982.
24. Ehrlich, M.; Rosen, N.; Kurihara, T.; Shalaby, I.; Greengard, P. DARPP-32 development in the caudate nucleus is independent of afferent input from the substatia nigra. Dev. Brain Res. 54:257-263; 1990.
25. Folkerth, R. D.; Durso, R. Survival and proliferation of nonneural tissues, with obstruction of cerebral ventricles, in a parkinsonian patient treated with fetal allografts [see comments]. Neurology 46:1219-1225; 1996.
26. Foster, G. A.; Schultzberg, M.; Hokfelt, T.; Goldstein, M.; Hemmings, H. C. Jr.; Ouimet, C. C.; Walaas, S. I.; Greengard, P. Development of a dopamine- and cyclic adenosine 3′:5′-monophosphate-regulated phosphoprotein (DARPP-32) in the prenatal rat central nervous system, and its relationship to the arrival of presumptive dopaminergic innervation. J. Neurosci. 7:1994-2018; 1987.
27. Freeman, T. B.; Sanberg, P. R.; Isacson, O. Development of the human striatum: Implications for fetal striatal transplantation in the treatmem of Huntington's disease. Cell Transplant. 4:539-545; 1995.
28. Fricker, R. A.; Annett, L. E.; Torres, E. M.; Dunnett, S. B. The placement of a striatal ibotenic acid lesion affects skilled forelimb use and the direction of drug-induced rotation. Brain Res. Bull. 41:409-416; 1996.
29. Fricker, R. A.; Barker, R. A.; Fawcett, J. W.; Dunnett, S. B. A comparative study of preparation techniques for improving the viability of striatal grafts using vital stains, in vitro cultures and in vivo grafts. Cell Transplant. 5: 599-611; 1996.
30. Fricker, R. A.; Torres, E. M.; Hume, S. P.; Myers, R.; Opacka-Juffery, J.; Ashworth, S.; Brooks, D. J.; Dunnett, S. B. The effect of donor age on the survival and function of embryonic striatal grafts in the adult rat brain II. Correlation between positron emission tomography and reaching behaviour. Neuroscience 79:711-721; 1997.
31. Grasbon-Frodl, E. M.; Nakao, N.; Lindvall, O.; Brundin, P. Developmental features of human striatal tissue transplanted in a rat model of Huntington's disease. Neurobiol. Dis. 3:299-311; 1997.
32. Graybiel, A. M.; Liu, F. C.; Dunnett, S. B. Intrastriatal grafts derived from fetal striatal primordia. 1. Phenotypy and modular organization. J. Neurosci. 9:3250-3271; 1989.
33. Hantraye, P.; Riche, D.; Maziere, M.; Isacson, O. A primate model of Huntington's disease: Behavioral and anatomical studies of unilateral excitotoxic lesions of the caudate-putamen in the baboon. Exp. Neurol. 108:91-104; 1990.
34. Hedreen, J. C.; Folstein, S. E. Early loss of neostriatal striosome neurons in Huntington's disease. J. Neuropathol. Exp. Neurol. 54:105-120; 1995.
35. Hedreen, J. C.; Peyser, C. E.; Folstein, S. E.; Ross, C. A. Neuronal loss in layers V and VI of cerebral cortex in Huntington's disease. Neurosci. Lett. 133:257-261; 1991.
36. Isacson, O.; Brundin, P.; Kelly, P. A. T.; Gage, F. H.; Björklund, A. Functional neuronal replacement by grafted striatal neurons in the ibotenic acid-lesioned striatum. Nature 311:458-460; 1984.
37. Kendall, A. L.; Rayment, F.; Torres, E. M.; Baker, H.; Ridley, R.; Dunnett, S. B. Functional integration of striatal allografts in a primate model of Huntington's disease. Nat. Med. 4:727-729; 1998.
38. Kopyov, O. V.; Jacques, S.; Lieberman, A.; Duma, C.; Eagle, K. S. Safety of intrastriatal neurotransplantation for Huntington's disease patients. Exp. Neurol. 149:97-108; 1998.
39. Kopyov, O. V.; Jaques, S.; Kurth, M.; Philpott, L.; Lee, A.; Patterson, M.; Duma, C.; Kogosov, E.; Lieberman, A.; Eagle, K. S. Neurotransplantation of fetal lateral ganglionic eminence tissue in three patients with Huntington's disease. Soc. Neurosci. Abstr. 22:227; 1996.
40. Labandeira-Garcia, J. L.; Guerra, M. Cortical stimulation induces fos expression in intrastriatal striatal grafts. Brain Res. 652:87-97; 1994.
41. Labandeira-Garcia, J. L.; Wictorin, K. Development and integration of intrastriatal striatal grafts implanted into long-term ibotenate lesions. J. Neural Transplant. Plast. 3:181-182; 1992.
42. Labandeira-Garcia, J..L.; Wictorin, K.; Cunningham, E. T.; Björklund, A. Development of intrastriatal striatal grafts and their afferent innervation from the host. Neuroscience 42:407-426; 1991.
43. Langston, J. W.; Widner, H.; Goetz, C. G.; Brooks, D. J.; Fahn, S.; Freeman, T. B.; Watts, R. Core Assessment Programme for Intracerebral Transplantations (CAPIT). Mov. Disord. 7:2-13; 1992.
44. Lehmann, J.; Fibiger, H. Acetylcholinesterase in the substantia nigra and caudate-putamen of the rat: Properties and localisation of dopaminergic neurons. J. Neurochem. 30:615-624; 1978.
45. Lindvall, O. Clinical application of neuronal grafts in Parkinson's disease. J. Neurol. 242:S54-S56; 1994.
46. Liste, I.; Rozas, G.; Guerra, M.; Labandeira-Garcia, J. L. Cortical stimulation induces Fos expression in striatal neurons via NMDA glutamate and dopamine receptors. Brain Res. 700:1-12; 1995.
47. Madrazo, I.; Franco-Bourland, R. E.; Castrejon, H.; Cuevas, C.; Ostrosky-Solis, F. Fetal striatal homotransplantation for Huntington's disease: First two case reports. Neurol. Res. 17:312-315; 1995.
48. Mamelak, A. N.; Eggerding, F. A.; Oh, D. S.; Wilson, E.; Davis, R. L.; Spitzer, R.; Hay, J. A.; Caton, W. L. Fatal cyst formation after fetal mesencephalic allograft transplant for Parkinson's disease. J. Neurosurg. 89:592-598; 1998.
49. Mason, S. T.; Fibiger, H. C. Kainic acid lesions of the striatum: Behavioural sequalae similar to Huntington's chorea. Brain Res. 155:313-329; 1978.
50. Mayer, E.; Brown, V.; Dunnett, S. B.; Robbins, T. Striatal graft-associated recovery of a lesion-induced performance deficit in the rat requires learning to use the transplant. Eur. J. Neurosci. 4:119-126; 1992.
51. McConnell, S.; Kaznowski, C. Cell cycle dependence of laminar determination in developing neocortex. Science 254:282-285; 1991.
52. McGeorge, A.; Faull, R. The organization and collateralization of corticostriate neurones in the motor and sensory cortex of the rat brain. Brain Res. 423:318-324; 1987.
53. Montoya, C.; Astell, S.; Dunnett, S. B. Effects of nigral and striatal grafts on skilled forelimb use in the rat. Prog. Brain Res. 82:459-466; 1990.
54. Morgan, J.; Curran, T. Stimulus-transcription coupling in neurons: Role of cellular immediate-early genes. Trends Neurosci. 12:459-462; 1989.
55. Naimi, S.; Jeny, R.; Hantraye, P.; Peschanski, M.; Riche, D. Ontogeny of human striatal DARPP-32 neurons in fetuses and following xenografting to the adult rat brain. Exp. Neurol. 137:15-25; 1996.
56. Nukao, N.; Brundin, P.; Funa, K.; Lindvall, O.; Odin, P. Trophic and protective effect of brain-derived neurotrophic factor on striatal DARPP-32-containing neurons in vitro. Dev. Brain Res. 90:92-101; 1995.
57. Nakao, N.; Grasbon-Frodl, E. M.; Widner, H.; Brundin, P. DARPP 32-rich zones in grafts of lateral ganglionic eminence govern the extent of functional recovery in skilled paw reaching in an animal model of Huntington's disease. Neuroscience 74:959-970; 1996.
58. Nakao, N.; Odin, P.; Brundin, P. Selective sub-dissection of the striatal primordium for cultures affects the yield of DARPP-32 containing neurones. Neuroreport 5:1081-1084; 1994.
59. Nakao, N.; Odin, P.; Lindvall, O.; Brundin, P. Differential trophic effects of basic fibroblast growth factor, insulin-like growth factor-1, and neurotrophin-3 on striatal neurons in culture. Exp. Neurol. 138:144-157; 1996.
60. Norman, A. B.; Norgren, A.; Wyatt, L.; Hildebrand, J.; Sanberg, P. R. The direction of apomorphine induced rotation behavior is dependent on the location of the excitotoxic lesions in the rat basal ganglia. Brain Res. 569: 139-147; 1992.
61. Norman, A.; Calderon, S. F.; Giordano, M.; Sanberg, P. R. Striatal tissue implants attenuate apomorphine induced rotational behavior in rats with unilateral kainic acid lesions. Neuropharmacology 27:333-336; 1988.
62. Nothias, F.; Onteniente, B.; Geffard, M.; Peschanski, M. Rapid growth of monoaminergic fibers into fetal cell transplants. Brain Res. 463:341-345; 1988.
63. Olsson, M.; Björklund, A.; Campbell, K. Early specification of striatal projection neurons and interneuronal subtypes in the lateral and medial ganglionic eminence. Neuroscience 84:867-876; 1998.
64. Olsson, M.; Campbell, K.; Wictorin, K.; Björklund, A. Projection neurons in fetal striatal transplants are predominantly derived from the lateral ganglionic eminence. Neuroscience 69:1169-1182; 1995.
65. Pakzaban, P.; Deacon, T. W.; Burns, L. H.; Isacson, O. Increased proportion of acetylcholinesterase-rich zones and improved morphological integration in host striatum of fetal grafts derived from the lateral but not the medial ganglionic eminence. Exp. Brain Res. 97:13-22; 1993.
66. Palfi, S.; Conde, F.; Riche, D.; Brouillet, E.; Dautry, C.; Mittoux, V.; Chibois, A.; Peschanski, M.; Hantraye, P. Fetal striatal allografts reverse cognitive deficits in a primate model of Huntington disease. Nat. Mod. 4:963-966; 1998.
67. Palfi, S.; Nguyen, J. P.; Brugieres, P.; Le Guerinel, C.; Hantraye, P.; Remy, P.; Rostaing, S.; Defer, G. L.; Cesaro, P.; Keravel, Y.; Peschanski, M. MRI-stereotactical approach for neural grafting in basal ganglia disorders. Exp. Neurol. 150:272-281; 1998.
68. Peschanski, M.; Cesaro, P.; Hantraye, P. Rationale for intrastriatal grafting of striatal neuroblasts in patients with Huntington's disease. Neuroscience 68:273-285; 1995.
69. Peschanski, M.; Cesaro, P.; Hantraye, P. What is needed versus what would be interesting to know before undertaking neural transplantation in patients with Huntington's disease. Neuroscience 71:899-900; 1996.
70. Phelps, E.; Brady, D.; Vaughn, J. The generation and differentiation of cholinergic neurons in the rat caudate-putamen. Dev. Brain Res. 46:47-60; 1989.
71. Pisa, M. Motor functions of the striatum in the rat: Critical role of the lateral region in tongue and forelimb reaching. Neuroscience 24:453-463; 1988.
72. Pundt, L. L.; Kondoh, T.; Conrad, J. A.; Low, W. C. Transplantation of human striatal tissue into a rodent model of Huntington's disease: Phenotypic expression of transplanted neurons and host-to-graft innervation. Brain Res. Bull. 39:23-32; 1996.
73. Quinn, N.; Brown, R.; Craufurd, D.; Goldman, S.; Hodges, J.; Kieburtz, K.; Lindvall, O.; MacMillan, J.; Roos, R. Core Assessment Program for Intracerebral Transplantation in Huntington's Disease (CAPIT-HD). Mov. Disord. 11:143-150; 1996.
74. Reier, P. J.; Bregman, B. S.; Wujek, J. R. Intraspinal transplantation of embryonic spinal cord tissue in neonatal and adult rats. J. Comp. Neurol. 247:275-296; 1986.
75. Reiner, A.; Albin, R. L.; Anderson, K. D.; D'Amato, C. J.; Penny, J. B.; Young, A. B. Differential loss of striatal projection neurons in Huntington's disease. Proc. Natl. Acad. Sci. USA 85:5733-5737; 1988.
76. Roos, R. A. C.; Pruyt, J. F. M.; deVries, J.; Bots, G. Th. A. M. Neuronal distribution in the putamen in Huntington's disease. J. Neurol. Neurosurg. Psychiatry 48:422-425; 1985.
77. Rutherford, A.; Garcia-Munoz, M.; Dunnett, S. B.; Arbuthnott, G. Electrophysiological demonstration of host cortical inputs to striatal grafts. Neurosci. Lett. 83:275-281; 1987.
78. Sagar, S.; Sharp, F.; Curran, T. Expression of c-fos protein in the brain: Metabolic mapping at the cellular level. Science 240:1328-1330; 1988.
79. Sanberg, P. R.; Calderon, S. F.; Giordano, M.; Tew, J. M.; Norman, A. B. The quinolinic acid model of Huntington's disease: Locomotor abnormalities. Exp. Neurol. 105:45-53; 1989.
80. Sanberg, P. R.; Henault, M. A.; Deckel, A. W. Locomotor hyperactivity: Effects of multiple striatal transplants in an animal model of Huntington's disease. Pharmacol. Biochem. Behav. 25:297-300; 1986.
81. Schumacher, J. M.; Hantraye, P.; Brownell, A. L.; Riche, D.; Madras, B. K.; Davenport, P. D.; Maziere, M.; Elmaleh, D. R.; Brownell, G. L.; Isacson, O. A primate model of Huntington's disease: Functional neural transplantation and CT-guided stereotactic procedures. Cell Transplant. 1:313-322; 1992.
82. Shannon, K. M.; Kordower, J. H. Neural transplantation for Huntington's disease: Experimental rational and recommendations for clinical trials. Cell Transplant. 5:339-352; 1996.
83. Smart, I. H. M.; Sturrock, R. R. Ontogeny of the neostriatum. In: Divac, I.; Oberg, R. G., eds. The neostriatum. Oxford: Pergamon; 1979:127-146.
84. Smith, L.; Hohmann, C.; Ebner, F. The development of specific cell types and connectivity in neocortical transplants. In: Björklund, A.; Stenevi, U., eds. Neural grafting in the mammalian CNS. Amsterdam: Elsevier; 1985: 249-255.
85. Sotelo, C.; Alvarado-Mallart, R. Cerebellar transplants: Immunocytochemical study of the specificity of Purkinje cells' inputs and outputs. In: Björklund, A.; Stenevi, U., eds. Neural grafting in the mammalian CNS. Amsterdam: Elsevier; 1985:205-215.
86. Stine, O. C.; Li, S.; Pleasant, N.; Wagsler, M. V.; Hedreen, J. C.; Ross, C. A. Expression of the mutant allele of IT-15 (the HD gene) in striatum and cortex of Huntington's disease patients. Hum. Mol. Genet. 4:15-18; 1995.
87. Sunde, N.; Zimmer, J.; Laurberg, S. Repair of neonatal irradiation-induced damage to the rat fascia dentata. Effects of delayed intracerebral transplantation. In: Björklund, A.; Stenevi, U., eds. Neural grafting in the mammalian CNS. Amsterdam: Elsevier; 1985:301-308.
88. The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72:971-983; 1993.
89. Vecsei, L.; Beal, M. F. Comparative behavioral and neurochemical studies with striatal kainic acid or quinolinic acid-lesioned rats. Pharmacol. Biochem. Behav. 39:473-478; 1991.
90. Vonsattel, J. P.; Myers, R. H.; Stevens, T. J.; Ferrante, R, J.; Bird, E. D.; Richardson, E. P. Neuropathological classification of Huntington's disease. J. Neuropathol. Exp. Neurol. 44:559-577; 1985.
91. Watts, C.; Brasted, P.; Dunnett, S. B. The morphology, integration and functional efficacy of striatal grafts differs between cell suspensions and tissue pieces. Cell Transplant. (in press).
92. Watts, C.; Brasted, P.; Eagle, D.; Dunnett, S. B. Embryonic donor age and dissection influences striatal graft development and functional integration in a rodent model of Huntington's disease. Exp. Neurol. (in press).
93. Watts, C.; Dunnett, S. B. Effects of severity of host striatal damage on the morphological development of intrastriatal transplants in a rodent model of Huntington's disease: Implications for timing of surgical intervention. J. Neurosurg. 89:267-274; 1998.
94. Watts, C.; McNamara, I.; Dunnett, S. B. There is no relationship between the number of striatal cells implanted and the patch volume of intrastriatal transplants in a rat model of Huntington's disease. Proc. Soc. Neurosci. 1: 42.2; 1997.
95. Watts, C.; McNamara, I.; Dunnett, S. B. Volume and differentiation of striatal grafts in rats: Relationship to the number of cells implanted. Cell Transplant. 9:65-72; 2000.
96. Watts, C.; Caldwell, M.; Dunnett, S. B. The development of intracerebral cell-suspension implants is influenced by the grafting medium. Cell Transplant. 7:573-583; 1998.
97. Watts, C.; Dunnett, S. B.; Rosser, A. E. Effect of embryonic donor age and dissection on the DARPP-32 content of cell suspensions used for intrastriatal transplantation. Exp. Neurol. 148:271-280; 1997.
98. Whishaw, I. Q.; O'Connor, W. T.; Dunnett, S. B. The contributions of motor cortex, nigrostriatal dopamine and caudate-putamen to skilled forelimb use in the rat. Brain 109:805-843; 1986.
99. Wictorin, K.; Björklund, A. Connectivity of striatal grafts implanted into the ibotenic acid-lesioned striatum-II. Cortical afferents. Neuroscience 30:297-311; 1989.
100. Wictorin, K.; Clarke, D. J.; Bolam, P. J.; Björklund, A. Fetal striatal neurons grafted into the ibotenate lesioned adult striatum: Efferent projections and synaptic contacts in the host globus pallidus. Neuroscience 37:301-315; 1990.
101. Wictorin, K.; Isacson, O.; Fischer, W.; Nothias, F.; Peschanski, M.; Björklund, A. Connectivity of striatal grafts implanted into the ibotenic acid-lesioned striatum-I. Subcortical afferents. Neuroscience 27:547-562; 1988.
102. Wictorin, K.; Simerly, R.; Isacson, O.; Swanson, L.; Björklund, A. Connectivity of striatal grafts implanted into the ibotenic acid-lesioned striatum-III. Efferent projecting graft neurons and their relation to host afferents within the grafts. Neuroscience 30:313-330; 1989.
103. Wictorin, K. Anatomy and connectivity of intrastriatal striatal transplants. Prog. Neurobiol. 38:611-639; 1992.
104. Wilson, C. J.; Xu, Z. C.; Emson, P. C.; Feler, C. Anatomical and physiological properties of the cortical and thalamic innervations of neostriatal tissue grafts. Prog. Brain Res. 82:417-426; 1990.